Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
9
×
national blog main
life sciences
biotech
clinical trials
boston blog main
san francisco blog main
startups
boston top stories
deals
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco
boston
detroit blog main
detroit top stories
drugs
investing
medical device
new enterprise associates
new york top stories
raleigh-durham blog main
san francisco top stories
texas blog main
texas top stories
achaogen
adams street partners
adha
aimmune therapeutics
akili interactive labs
akouos
alafair bioscienes
allergy
alto
amyotrophic lateral sclerosis
anaphylaxis
andrew oxtoby
antibiotics
What
drug
9
×
therapeutics
9
×
medicines
approved
fda
ipo
treat
company
developing
disease
latest
momentum
rare
therapy
affects
agency
aimmune
allergy
americans
announced
approval
awarded
backs
bacteria
based
bets
big
biopharma
biotech
black
brings
building
business
cancer
candidate
catch
cholesterol
click
clinic
combo
Language
unset
Current search:
therapeutics
×
drug
×
fda
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed